However, in recent years, SBSN has been reported to be aberrantly expressed in certain malignancies, and inhibition of SBSN may lead to the inhibition of cancer cell proliferation, invasion, and metastasis, suggesting that SBSN may be associated with tumor progression. This evidence concerns the gene SBSN and neoplasm.